This HTML5 document contains 157 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1093/ANNONC/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33399785
rdf:type
wikibase:Item
schema:description
2012年の論文 artículo científico publicado en 2012 artigo científico (publicado na 2012) 2012年論文 vědecký článek مقالة علمية научни чланак vitskapeleg artikkel naučni članak מאמר מדעי article scientifique (publié 2012) επιστημονικό άρθρο 2012年论文 научная статья wissenschaftlicher Artikel 2012年论文 tudományos cikk artykuł naukowy мақолаи илмӣ artigo científico article científic 2012年論文 vedecký článok artikull shkencor articol științific article scientific mokslinis straipsnis 2012年論文 2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած 2012 թվականի փետրվարին հրատարակված գիտական հոդված наукова стаття, опублікована в лютому 2012 vitenskapelig artikkel bilimsel makale سائنسی مضمون 2012年论文 2012年论文 ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2012년 논문 tieteellinen artikkeli artículu científicu espublizáu en 2012 2012 nî lūn-bûn مقالهٔ علمی wetenschappelijk artikel мақолаи илмӣ scienca artikolo artigo científico (publicado na 2012) vetenskaplig artikel scientific article 2012年論文 artikulong pang-agham teaduslik artikkel 2012年論文 2012年论文 научна статия articolo scientifico videnskabelig artikel (udgivet 2012) სამეცნიერო სტატია บทความทางวิทยาศาสตร์ bài báo khoa học 2012年论文 научни чланак
p:P577
wds:Q33399785-701D5622-D8DD-493D-AC11-2D12230196B8
wdt:P577
2012-02-16T00:00:00Z
p:P2860
wds:Q33399785-1385452E-CCB0-4259-A4C5-85FBCFA3FC94 wds:Q33399785-1A7ABC32-37DC-4BA7-BC25-F9E9406D44D2 wds:Q33399785-358C7703-BBDB-4C64-91B6-9FEBFD126C1A wds:Q33399785-3D93F19F-9FC3-425A-9248-15462E873A4B wds:Q33399785-AE8FB997-DBDD-43C9-B648-00A037D01324 wds:Q33399785-B1BE099C-64EB-4AFC-BCE2-11AB88840264 wds:Q33399785-B1F2462F-123C-4F16-9720-F2DACC14AB3D wds:Q33399785-CBDF6D22-1D08-4815-BEF9-EFA32C8A233C wds:Q33399785-D54B48AE-D098-47E8-BC30-0B506F93D842 wds:Q33399785-E1BCA14B-3D6C-4350-AF0B-18E18207D082 wds:Q33399785-F53D6FC2-9063-4284-A399-8F4358173254 wds:Q33399785-F5E2ED0F-C4C7-4D71-896A-088256B012DA wds:Q33399785-FFF0F0F8-7270-48E8-B5D0-888830CDDB1A wds:Q33399785-4A0B7DAB-36C1-41C2-9DEB-5477877D6074 wds:Q33399785-68F7614D-9D4F-4CC7-A736-C3F929718EED wds:Q33399785-7742C3C5-F73D-4E23-9AD9-23DA868BC39E wds:Q33399785-7A03CA45-4382-40B8-942B-757E9BAAE00C wds:Q33399785-7FC66717-B43E-4C70-B270-F6554C61A927 wds:Q33399785-A2C276AB-04C1-4C44-9EB2-8B1753C4F07C
wdt:P2860
wd:Q27650860 wd:Q29615476 wd:Q34089525 wd:Q24658237 wd:Q34114767 wd:Q28278736 wd:Q54621891 wd:Q35008979 wd:Q33500432 wd:Q36883658 wd:Q35011280 wd:Q33375771 wd:Q27860904 wd:Q37132598 wd:Q72354126 wd:Q28278682 wd:Q36780614 wd:Q29614539 wd:Q74599247
p:P2093
wds:Q33399785-6CBD9EA8-59D3-4FCB-9FDA-C2B3DE07A1B2 wds:Q33399785-61600378-6AB3-491B-B25C-0F0F0C257E9A wds:Q33399785-9C9CC74E-E07E-4A22-A62D-715A1DC1287C wds:Q33399785-92E0CC75-0275-4475-9970-4901E68B3048 wds:Q33399785-F768A4CB-9963-4043-B6A6-0E8BFF010370 wds:Q33399785-F0044328-5687-42B5-A611-3E41B647923F wds:Q33399785-0EC6C4E3-6591-4A18-B1E3-D43099760307 wds:Q33399785-412E7F68-6C9A-42CD-BC2E-D8825B5C8961 wds:Q33399785-2CD21A79-D896-4ECC-98E1-903151C5C95F
wdt:P2093
S Wind G A Otterson R C Doebele P Stopfer R Kaiser Y Zhao A M Traynor D R Camidge P Conkling
rdfs:label
A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer
skos:prefLabel
A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer
schema:name
A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer
p:P1476
wds:Q33399785-26961943-0D2F-4092-A3D4-4A6137A0A51B
wdt:P1476
A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer
p:P304
wds:Q33399785-BF099CA6-1F27-4A26-B1E1-4B5EC51EF6EF
wdt:P304
2094-2102
p:P31
wds:Q33399785-BEBF869E-EECA-48A9-8C93-7E0659420526
wdt:P31
wd:Q13442814
p:P921
wds:Q33399785-E879AFCA-3D66-4E95-AA2B-5F7FA62478E2 wds:Q33399785-90615BBC-EC00-46FC-82F9-6CE18432A1A5 wds:Q33399785-83C4A887-3177-4F23-A1E9-28D4713032D4
wdt:P921
wd:Q47912 wd:Q423762 wd:Q415588
p:P698
wds:Q33399785-5D5685A0-A8F9-4269-B56E-1B6433B3EBD5
wdtn:P698
n6:22345119
wdt:P698
22345119
p:P1433
wds:Q33399785-662EB6B4-5838-4EBF-9014-717EE074F436
wdt:P1433
wd:Q326122
p:P433
wds:Q33399785-04D4E27F-3BD8-496F-8440-C00F57178BF0
p:P478
wds:Q33399785-687DCCCC-9093-47A4-B386-18874A445346
wdt:P433
8
wdt:P478
23
p:P356
wds:Q33399785-1CD620F0-2DAF-40C6-AB3E-9AA115217BBE
wdtn:P356
n12:MDR596
wdt:P356
10.1093/ANNONC/MDR596
p:P5875
wds:Q33399785-C14500E0-3152-47DE-A046-39ED08D92FD2
wdt:P5875
221842575
p:P932
wds:Q33399785-BC508C13-4314-4AF5-B8CD-6BD725096C64
wdt:P932
4141207